Compare $LUNG vs $MBOT | Chartloom

Compare

$LUNG vs $MBOT

Pulmonx Corp · Microbot Medical Inc

LUNG

Pulmonx Corp

MBOT

Microbot Medical Inc

Compare $LUNG vs $MBOT

Comparing Pulmonx Corp and Microbot Medical Inc

LUNGPulmonx Corp

MBOTMicrobot Medical Inc

LUNGPulmonx Corp

Market cap

$78M

P/E (TTM)

—

Forward P/E (NTM)

—

Forward P/S (NTM)

0.80x

Rev growth (TTM)

-3.4%

YTD performance

-20.0%

52W performance

3.4%

FCF yield

-39.5%

MBOTMicrobot Medical Inc

Market cap

$72M

P/E (TTM)

—

Forward P/E (NTM)

—

Forward P/S (NTM)

14.23x

Rev growth (TTM)

—

YTD performance

-49.3%

52W performance

-67.5%

FCF yield

-24.9%

Add ticker

Add up to 1 more ticker to compare

Relative performance

Each ticker starts at 100. 110 means +10% from the start of this window — not a $110 share price.

LUNG

MBOT

Detailed metrics comparison

LUNG

Pulmonx Corp

MBOT

Microbot Medical Inc

Market Cap

LUNG$78M

MBOT$72M

Enterprise Value

LUNG$59M

MBOT$69M

Price

LUNG$1.84

MBOT$1.07

P/E Ratio

LUNGN/A

MBOTN/A

P/S Ratio

LUNG0.89x

MBOT207.69x

EV/Sales

LUNG0.68x

MBOT198.58x

EV/EBITDA

LUNG0.00x

MBOT2.92x

P/B Ratio

LUNG2.01x

MBOT1.13x

P/FCF Ratio

LUNGN/A

MBOTN/A

EV/FCF

LUNG-1.94x

MBOT-3.83x

PEG Ratio

LUNGN/A

MBOTN/A

Forward P/E (NTM)

LUNGN/A

MBOTN/A

Forward P/S (NTM)

LUNG0.80x

MBOT14.23x

Revenue (TTM)

LUNG$87M

MBOT$346K

Revenue Growth (YoY)

LUNG-3.4%

MBOTN/A

Forward Rev Growth

LUNG8.5%

MBOT306.4%

Gross Margin (TTM)

LUNG77.1%

MBOT-185.3%

Operating Margin (TTM)

LUNG0.0%

MBOT0.0%

EBITDA Margin (TTM)

LUNG-49.7%

MBOT-5335.3%

Net Margin (TTM)

LUNG-55.0%

MBOT-4722.3%

FCF Margin (TTM)

LUNG-35.1%

MBOT-5181.8%

Net Income (TTM)

LUNG$-48M

MBOT$-16M

FCF (TTM)

LUNG$-31M

MBOT$-18M

EPS (TTM)

LUNG-$1.13

MBOT-$0.24

ROE (TTM)

LUNG-9666.0%

MBOT-2187.0%

ROA (TTM)

LUNG-3832.0%

MBOT-2077.0%

ROIC (TTM)

LUNG-5528.0%

MBOT-2187.0%

Cash

LUNG$56M

MBOT$3M

Debt

LUNG$38M

MBOT$0

Net Cash/Debt

LUNG$18M

MBOT$3M

Current Ratio (TTM)

LUNG4.32x

MBOT18.56x

Quick Ratio (TTM)

LUNG3.37x

MBOT17.63x

Debt/Equity (TTM)

LUNG0.96x

MBOT0.00x

Debt/Assets (TTM)

LUNG0.0%

MBOT0.0%

Interest Coverage (TTM)

LUNGN/A

MBOTN/A

Net Debt/EBITDA (TTM)

LUNG0.00x

MBOT0.00x

Beta

LUNG0.27

MBOT1.01

52W Performance

LUNG3.4%

MBOT-67.5%

YTD Performance

LUNG-20.0%

MBOT-49.3%

% from 52W High

LUNG-36.3%

MBOT-67.4%

% from 52W Low

LUNG62.8%

MBOT1.9%

Asset Turnover (TTM)

LUNG0.70x

MBOT0.00x

FCF Yield (TTM)

LUNG-39.5%

MBOT-24.9%

Earnings Yield (TTM)

LUNG-61.9%

MBOT-22.7%

Dividend Yield (TTM)

LUNGN/A

MBOTN/A

Rule of 40

LUNG-38.5

MBOT-5,181.8

EV/GP/RG

LUNG0.08

MBOTN/A

Ticker research

View LUNG research View MBOT research

Metric	LUNG Pulmonx Corp	MBOT Microbot Medical Inc
Market & Valuation
Market Cap	$78M	$72M
Enterprise Value	$59M	$69M
Price	$1.84	$1.07
P/E Ratio	N/A	N/A
P/S Ratio	0.89x	207.69x
EV/Sales	0.68x	198.58x
EV/EBITDA	0.00x	2.92x
P/B Ratio	2.01x	1.13x
P/FCF Ratio	N/A	N/A
EV/FCF	-1.94x	-3.83x
PEG Ratio	N/A	N/A
Forward P/E (NTM)	N/A	N/A
Forward P/S (NTM)	0.80x	14.23x
Revenue & Growth
Revenue (TTM)	$87M	$346K
Revenue Growth (YoY)	-3.4%	N/A
Forward Rev Growth	8.5%	306.4%
Profitability
Gross Margin (TTM)	77.1%	-185.3%
Operating Margin (TTM)	0.0%	0.0%
EBITDA Margin (TTM)	-49.7%	-5335.3%
Net Margin (TTM)	-55.0%	-4722.3%
FCF Margin (TTM)	-35.1%	-5181.8%
Net Income (TTM)	$-48M	$-16M
FCF (TTM)	$-31M	$-18M
EPS (TTM)	-$1.13	-$0.24
ROE (TTM)	-9666.0%	-2187.0%
ROA (TTM)	-3832.0%	-2077.0%
ROIC (TTM)	-5528.0%	-2187.0%
Financial Health
Cash	$56M	$3M
Debt	$38M	$0
Net Cash/Debt	$18M	$3M
Current Ratio (TTM)	4.32x	18.56x
Quick Ratio (TTM)	3.37x	17.63x
Debt/Equity (TTM)	0.96x	0.00x
Debt/Assets (TTM)	0.0%	0.0%
Interest Coverage (TTM)	N/A	N/A
Net Debt/EBITDA (TTM)	0.00x	0.00x
Performance
Beta	0.27	1.01
52W Performance	3.4%	-67.5%
YTD Performance	-20.0%	-49.3%
% from 52W High	-36.3%	-67.4%
% from 52W Low	62.8%	1.9%
Efficiency & Yields
Asset Turnover (TTM)	0.70x	0.00x
FCF Yield (TTM)	-39.5%	-24.9%
Earnings Yield (TTM)	-61.9%	-22.7%
Dividend Yield (TTM)	N/A	N/A
Other
Rule of 40	-38.5	-5,181.8
EV/GP/RG	0.08	N/A
Ticker research	View LUNG research	View MBOT research

Valuation

P/S Ratio

LUNG

0.89x

MBOT

207.69x

EV/FCF

MBOT

-3.83x

LUNG

-1.94x

Growth & revenue

Revenue Growth TTM

LUNG

-3.4%

Forward Revenue Growth

MBOT

306.4%

LUNG

8.5%

Profitability & performance

Gross Margin

LUNG

77.1%

MBOT

-185.3%

ROE

MBOT

-2187.0%

LUNG

-9666.0%

FCF Yield %

MBOT

-24.9%

LUNG

-39.5%

52-Week Performance

LUNG

3.4%

MBOT

-67.5%

Detailed metrics comparison

LUNG

Pulmonx Corp

MBOT

Microbot Medical Inc

Market Cap

LUNG$78M

MBOT$72M

Enterprise Value

LUNG$59M

MBOT$69M

Price

LUNG$1.84

MBOT$1.07

P/E Ratio

LUNGN/A

MBOTN/A

P/S Ratio

LUNG0.89x

MBOT207.69x

EV/Sales

LUNG0.68x

MBOT198.58x

EV/EBITDA

LUNG0.00x

MBOT2.92x

P/B Ratio

LUNG2.01x

MBOT1.13x

P/FCF Ratio

LUNGN/A

MBOTN/A

EV/FCF

LUNG-1.94x

MBOT-3.83x

PEG Ratio

LUNGN/A

MBOTN/A

Forward P/E (NTM)

LUNGN/A

MBOTN/A

Forward P/S (NTM)

LUNG0.80x

MBOT14.23x

Revenue (TTM)

LUNG$87M

MBOT$346K

Revenue Growth (YoY)

LUNG-3.4%

MBOTN/A

Forward Rev Growth

LUNG8.5%

MBOT306.4%

Gross Margin (TTM)

LUNG77.1%

MBOT-185.3%

Operating Margin (TTM)

LUNG0.0%

MBOT0.0%

EBITDA Margin (TTM)

LUNG-49.7%

MBOT-5335.3%

Net Margin (TTM)

LUNG-55.0%

MBOT-4722.3%

FCF Margin (TTM)

LUNG-35.1%

MBOT-5181.8%

Net Income (TTM)

LUNG$-48M

MBOT$-16M

FCF (TTM)

LUNG$-31M

MBOT$-18M

EPS (TTM)

LUNG-$1.13

MBOT-$0.24

ROE (TTM)

LUNG-9666.0%

MBOT-2187.0%

ROA (TTM)

LUNG-3832.0%

MBOT-2077.0%

ROIC (TTM)

LUNG-5528.0%

MBOT-2187.0%

Cash

LUNG$56M

MBOT$3M

Debt

LUNG$38M

MBOT$0

Net Cash/Debt

LUNG$18M

MBOT$3M

Current Ratio (TTM)

LUNG4.32x

MBOT18.56x

Quick Ratio (TTM)

LUNG3.37x

MBOT17.63x

Debt/Equity (TTM)

LUNG0.96x

MBOT0.00x

Debt/Assets (TTM)

LUNG0.0%

MBOT0.0%

Interest Coverage (TTM)

LUNGN/A

MBOTN/A

Net Debt/EBITDA (TTM)

LUNG0.00x

MBOT0.00x

Beta

LUNG0.27

MBOT1.01

52W Performance

LUNG3.4%

MBOT-67.5%

YTD Performance

LUNG-20.0%

MBOT-49.3%

% from 52W High

LUNG-36.3%

MBOT-67.4%

% from 52W Low

LUNG62.8%

MBOT1.9%

Asset Turnover (TTM)

LUNG0.70x

MBOT0.00x

FCF Yield (TTM)

LUNG-39.5%

MBOT-24.9%

Earnings Yield (TTM)

LUNG-61.9%

MBOT-22.7%

Dividend Yield (TTM)

LUNGN/A

MBOTN/A

Rule of 40

LUNG-38.5

MBOT-5,181.8

EV/GP/RG

LUNG0.08

MBOTN/A

Ticker research

View LUNG research View MBOT research

Metric	LUNG Pulmonx Corp	MBOT Microbot Medical Inc
Market & Valuation
Market Cap	$78M	$72M
Enterprise Value	$59M	$69M
Price	$1.84	$1.07
P/E Ratio	N/A	N/A
P/S Ratio	0.89x	207.69x
EV/Sales	0.68x	198.58x
EV/EBITDA	0.00x	2.92x
P/B Ratio	2.01x	1.13x
P/FCF Ratio	N/A	N/A
EV/FCF	-1.94x	-3.83x
PEG Ratio	N/A	N/A
Forward P/E (NTM)	N/A	N/A
Forward P/S (NTM)	0.80x	14.23x
Revenue & Growth
Revenue (TTM)	$87M	$346K
Revenue Growth (YoY)	-3.4%	N/A
Forward Rev Growth	8.5%	306.4%
Profitability
Gross Margin (TTM)	77.1%	-185.3%
Operating Margin (TTM)	0.0%	0.0%
EBITDA Margin (TTM)	-49.7%	-5335.3%
Net Margin (TTM)	-55.0%	-4722.3%
FCF Margin (TTM)	-35.1%	-5181.8%
Net Income (TTM)	$-48M	$-16M
FCF (TTM)	$-31M	$-18M
EPS (TTM)	-$1.13	-$0.24
ROE (TTM)	-9666.0%	-2187.0%
ROA (TTM)	-3832.0%	-2077.0%
ROIC (TTM)	-5528.0%	-2187.0%
Financial Health
Cash	$56M	$3M
Debt	$38M	$0
Net Cash/Debt	$18M	$3M
Current Ratio (TTM)	4.32x	18.56x
Quick Ratio (TTM)	3.37x	17.63x
Debt/Equity (TTM)	0.96x	0.00x
Debt/Assets (TTM)	0.0%	0.0%
Interest Coverage (TTM)	N/A	N/A
Net Debt/EBITDA (TTM)	0.00x	0.00x
Performance
Beta	0.27	1.01
52W Performance	3.4%	-67.5%
YTD Performance	-20.0%	-49.3%
% from 52W High	-36.3%	-67.4%
% from 52W Low	62.8%	1.9%
Efficiency & Yields
Asset Turnover (TTM)	0.70x	0.00x
FCF Yield (TTM)	-39.5%	-24.9%
Earnings Yield (TTM)	-61.9%	-22.7%
Dividend Yield (TTM)	N/A	N/A
Other
Rule of 40	-38.5	-5,181.8
EV/GP/RG	0.08	N/A
Ticker research	View LUNG research	View MBOT research